Medical/Pharmaceuticals
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax
* Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in the 2001 anthrax attack * Provides the most potent bactericidal ability that no other PEP antibiotics in the market can exhibit * Further developments are planned to conduct with a licensing/col...
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders
CAMBRIDGE, Mass., Jan. 26, 2023 /PRNewswire/ -- HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated byHarbour BioMed (HKEX: 02142), announced that it completed seed financing to advance its leading programs, novel antibody therapies to treat congenital adrenal hype...
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue in 11 countries, only 1 year after approval in Korea
"Expected to change GERD drug market landscape" * Application for product approval of Fexuclue, a new drug for gastroesophageal reflux disease (GERD), has been completely submitted toColombia ,Vietnam, and Saudi Arabia * NDA submissions in 11 countries completed in the shortest time among K...
GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy
SEOUL, South Korea, Jan. 26, 2023 /PRNewswire/ -- GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, announced that it has entered into a strategic research collaboration with a US-based biopharma company for the development of in vivo gene editing therapies. This c...
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies
NANJING, China, Jan. 25, 2023 /PRNewswire/ -- As the tissue engineering and regenerative treatment industry has shown tremendous potential in clinical practices in recent years worldwide,China's blue ocean market welcomes the first wave of acquisitions. ReLive Biotechnologies, Ltd. ("ReLive" or ...
MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study
GENEVA, Jan. 26, 2023 /PRNewswire/ -- The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US inOctober 2022. SELUTION ...
Correction - Health in Transportation Releases New Smartphone Face-Scanning Application Aimed at Uncovering Potentially Serious Health Concerns in Professional Drivers
Correction Notice Please note the following corrections to the Press Release issued Jan 17, 2023 : * The CDL Health Scanner is a product of Health in Transportation. NuraLogix does not hold any liability for any applications distributed under the Health in Transportation name. * Nur...
Breg Partners with Correal International to Provide Orthopedic Products to Physicians & Patients in China
CARLSBAD, Calif., Jan. 26, 2023 /PRNewswire/ -- Breg, Inc., a leading orthopedic bracing and billing services company, announced today that it has partnered with medical device supplier Coreal International to bring its broad portfolio of bracing and cold therapy products to Chinese physicians an...
CO.DON finally saved - investor has taken over the business operations of the Leipzig-based biopharmacy company with an additional location in Teltow, Brandenburg.
CO.DON continues business operations as a GmbH (limited liability company) LEIPZIG and TELTOW, GERMANY, Jan. 26, 2023 /PRNewswire/ -- With effect from 20.01.2023, CO.DON's business activities will be continued in the legal form of a GmbH (limited liability company) following a transferring reorga...
PlumCare RWE partners with Lifebit on Greece's newborn genomic sequencing program, BeginNGS
* PlumCare RWE and Lifebit enter a three-year partnership to support Greece's pioneering national newborn genomic sequencing program, BeginNGS. * Researchers will be able to access and analyse data securely in combination with global cohorts, whilst ensuring data is kept safe, private and in p...
Singleron launches single cell eQTL analysis as part of their sequencing service
A new bioinformatic pipeline to investigate single cell eQTL analysis is now
offered in the sequencing service from Singleron Biotechnologies.
COLOGNE, Germany, Jan. 25, 2023 /PRNewswire/ -- Bioinformatic experts at
Singleron Biotechnologies
Malaysia Healthcare Partners with AirAsia
Cambodian Passengers Can Kickstart 2023 with Wellness Travel to Malaysia PHNOM PENH, Cambodia, Jan. 25, 2023 /PRNewswire/ -- In its pursuit to providing accessible preventive healthcare and wellness options for global citizens, Malaysia Healthcare Travel Council (MHTC) partners with AirAsia, off...
DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease
Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of life, and pain medication usage out to two years post-injection in patients with lumbar DDD. SALT LAKE CITY, Jan. 25, 2023 /PRNewswire/ -- DiscGenics, I...
Metabolon Secures $25 Million of Funding to Accelerate Growth
MORRISVILLE, N.C, Jan. 24, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today announced that it has closed on$25 million of additional ...
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a furtherA$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal...
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination
NEW YORK, Jan. 20, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ: UPTD) today announced that, in order to extend the date by which the Company mush complete its initial business combination fromJanuary 19, 2023 to February 19, 2023, for each public share that...
CARsgen Presents Results on Anti-Claudin18.2-mAb AB011 at ASCO GI
SHANGHAI, Jan. 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thata poster presentation highlighting the Phase 1 preliminary result...
International Symposium at the Vatican on Hansen's Disease To Focus on Theme of "Leave No One Behind"
TOKYO, Jan. 20, 2023 /PRNewswire/ -- French Raoul Follereau Fondation, Italian Association Amici di Raoul Follereau and Sasakawa Leprosy (Hansen's Disease) Initiative, in collaboration with the Dicastery for Promoting Integral Human Development, will co-host the "International Symposium at the Va...
SK bioscience Appoints New Executives to Accelerate New Growth Strategies
* Two biopharmaceutical experts join SK bioscience to strengthen the future strategies * With recruitment of global talent and capabilities accumulated during the COVID-19 pandemic, SK bioscience will continue to achieve sustainable growth SEOUL, South Korea, Jan. 20, 2023 /PRNewswire/ -- SK ...
A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties
COVID-19 Prevention and Treatment Live-Streaming Training for Rural Doctors Attracted over 1 Million Views HONG KONG, Jan. 20, 2023 /PRNewswire/ -- On January 16, the second stage of "A Healthy Winter Action" initiated by Fosun Foundation in conjunction with other institutions kicked off, with 1...
Week's Top Stories
Most Reposted
BoomerangFX Launches ChatGPT AI Search Advertising for Aesthetic, Wellness and Private-Pay Healthcare Practices, Powered by AUVIA™ AI Clinic Co-Pilot
[Picked up by 1316 media titles]
2026-11-17 23:03Manulife announces Subordinated Debenture issue
[Picked up by 1206 media titles]
2026-11-17 06:45The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1176 media titles]
2026-11-14 13:23Sunbit to Enter Personal Loans in 2027 Along Its Growth Journey: NYSE Content Update
[Picked up by 1118 media titles]
2026-11-18 21:55Cision MCP Brings Consumer Intelligence into Everyday Workflows
[Picked up by 1116 media titles]
2026-11-19 23:00